A simple point-of-care testing device for anemia could provide more rapid diagnosis of the common blood disorder and allow inexpensive at-home self-monitoring of persons with chronic forms of the disease. … Continue Reading FDA-funded study for one-minute point-of-care anemia test shows promise.
An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device’s inventors at the Stanford University … Continue Reading Stanford researchers invent nanotech microchip to diagnose type-1 diabetes.
Review of ADHD drug approvals highlights gaps between approval process, long-term safety assessment.
Review of ADHD drug approvals highlights gaps between approval process, long-term safety assessment. Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events. The study highlights gaps in how the long-term safety of drugs intended for chronic use in children is assessed as part of the FDA approval process.
Thoughts health innovators?
Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease, according to a study in the Journal of … Continue Reading Adults stop anti-rejection drugs after partial stem-cell transplant reverses sickle cell disease.
“When you discover something novel the medical imperative is to come up with a good use for it” ….. Paul Janssen I was approached to report on a Reuters webinar … Continue Reading Healthinnovations on Thomson Reuters: New Techniques in Drug Discovery.
We know that obesity kills, we know that obesity costs the global economy billions, what we don’t know is how to sustainably treat obesity to bring the former points to … Continue Reading Healthinnovations on the BBC World panel on the Danish ‘Fat Tax’ [unedited]
Healthinnovations is not only on google plus but healthinnovations enjoys google +. I like the clean-cut asymmetrical minimalist design, I like the ease of use and I like the reach. … Continue Reading Healthinnovations on pharma brands on google +
To begin a QR code or Quick Response code is a 2-dimensional barcode which can be linked to a website or contain extra documentation, there’s one over there to the … Continue Reading Healthinnovations on QR codes in pharma & healthcare marketing.
I have a story, it’s nothing unusual. It’s about a teenager who found she couldn’t stand up straight. Worried parent’s told her to stand up straight, female family members worriedly … Continue Reading Healthinnovations in Psychology Part Two
The mental health patient is the forgotten patient…Let’s talk mental illness, does it make you feel uncomfortable? Does it worry you that speaking about it may lead people to believe … Continue Reading Health Innovations in Psychology Part One
I have just read a tweet about incentives being offered to women to take Mammograms in the US. These “mammogram parties” will offer incentives such as chocolate fondue, massages and … Continue Reading Why is it irresponsible to offer women incentives to take mammograms?
Before we begin these are my personal views and don’t necessarily reflect the views of my employer. In this post I will be exploring whether Japanese culture and new methodologies can co-exist in … Continue Reading Healthcare Innovations In Japan Part Two
Before we begin these are my personal views and don’t necessarily reflect the views of my employer. I love Japan, I love the people, I love the breath-taking scenery, I love the … Continue Reading Health Innovations in Japan Part One
Before we begin these are my personal views and don’t necessarily reflect the views of my employer. Whilst researching pharmaceutical sales force recently I realised that I couldn’t find one … Continue Reading Why The Pharmaceutical Industry Still Needs Sales Force.